During the past decade, Mehrad Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mehrad Hospital" are "HER2-positive Breast Cancer" (1 trials) and "Malignant Neoplasm of Breast" (1 trials). Many other conditions were trialed in "Mehrad Hospital" in a lesser frequency.

Most popular intervention types in "Mehrad Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Docetaxel" (1 trials), "Pertuzumab" (1 trials), "Trastuzumab" (1 trials) and "Trastuzumab plus docetaxel (for four 21-day cycles) after four 14-day cycles of Doxorubicin plus cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mehrad Hospital" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Mehrad Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mehrad Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mehrad Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".